vs
BALCHEM CORP（BCPC）与Rocket Lab Corp（RKLB）财务数据对比。点击上方公司名可切换其他公司
BALCHEM CORP的季度营收约是Rocket Lab Corp的1.5倍（$263.6M vs $179.7M），BALCHEM CORP净利率更高（14.9% vs -29.5%，领先44.3%），Rocket Lab Corp同比增速更快（35.7% vs 9.8%），过去两年Rocket Lab Corp的营收复合增速更高（39.2% vs 4.9%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
Rocket Lab是公开上市的航空航天制造商及发射服务提供商，旗下Electron轨道火箭主打小型卫星发射，截至2026年1月已成功完成超75次任务，是全球现役发射次数最多的小型运载火箭。公司还开发了Electron的亚轨道改型HASTE用作高超音速技术测试平台，下一代可复用中型运载火箭Neutron目前也在研发中。
BCPC vs RKLB — 直观对比
营收规模更大
BCPC
是对方的1.5倍
$179.7M
营收增速更快
RKLB
高出25.9%
9.8%
净利率更高
BCPC
高出44.3%
-29.5%
两年增速更快
RKLB
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $179.7M |
| 净利润 | $39.2M | $-52.9M |
| 毛利率 | 35.6% | 38.0% |
| 营业利润率 | 19.8% | -28.4% |
| 净利率 | 14.9% | -29.5% |
| 营收同比 | 9.8% | 35.7% |
| 净利润同比 | 16.8% | -1.1% |
| 每股收益（稀释后） | $1.21 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCRKLB
| Q4 25 | $263.6M | $179.7M | ||
| Q3 25 | $267.6M | $155.1M | ||
| Q2 25 | $255.5M | $144.5M | ||
| Q1 25 | $250.5M | $122.6M | ||
| Q4 24 | $240.0M | $132.4M | ||
| Q3 24 | $239.9M | $104.8M | ||
| Q2 24 | $234.1M | $106.3M | ||
| Q1 24 | $239.7M | $92.8M |
净利润BCPCRKLB
| Q4 25 | $39.2M | $-52.9M | ||
| Q3 25 | $40.3M | $-18.3M | ||
| Q2 25 | $38.3M | $-66.4M | ||
| Q1 25 | $37.1M | $-60.6M | ||
| Q4 24 | $33.6M | $-52.3M | ||
| Q3 24 | $33.8M | $-51.9M | ||
| Q2 24 | $32.1M | $-41.6M | ||
| Q1 24 | $29.0M | $-44.3M |
毛利率BCPCRKLB
| Q4 25 | 35.6% | 38.0% | ||
| Q3 25 | 35.7% | 37.0% | ||
| Q2 25 | 36.4% | 32.1% | ||
| Q1 25 | 35.2% | 28.8% | ||
| Q4 24 | 36.0% | 27.8% | ||
| Q3 24 | 35.6% | 26.7% | ||
| Q2 24 | 35.5% | 25.6% | ||
| Q1 24 | 34.0% | 26.1% |
营业利润率BCPCRKLB
| Q4 25 | 19.8% | -28.4% | ||
| Q3 25 | 20.4% | -38.0% | ||
| Q2 25 | 20.1% | -41.3% | ||
| Q1 25 | 20.4% | -48.3% | ||
| Q4 24 | 19.8% | -38.9% | ||
| Q3 24 | 20.0% | -49.5% | ||
| Q2 24 | 19.6% | -40.7% | ||
| Q1 24 | 17.4% | -46.4% |
净利率BCPCRKLB
| Q4 25 | 14.9% | -29.5% | ||
| Q3 25 | 15.1% | -11.8% | ||
| Q2 25 | 15.0% | -46.0% | ||
| Q1 25 | 14.8% | -49.5% | ||
| Q4 24 | 14.0% | -39.5% | ||
| Q3 24 | 14.1% | -49.6% | ||
| Q2 24 | 13.7% | -39.2% | ||
| Q1 24 | 12.1% | -47.7% |
每股收益（稀释后）BCPCRKLB
| Q4 25 | $1.21 | $-0.09 | ||
| Q3 25 | $1.24 | $-0.03 | ||
| Q2 25 | $1.17 | $-0.13 | ||
| Q1 25 | $1.13 | $-0.12 | ||
| Q4 24 | $1.03 | $-0.11 | ||
| Q3 24 | $1.03 | $-0.10 | ||
| Q2 24 | $0.98 | $-0.08 | ||
| Q1 24 | $0.89 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $1.0B |
| 总债务越低越好 | — | $152.4M |
| 股东权益账面价值 | $1.3B | $1.7B |
| 总资产 | $1.7B | $2.3B |
| 负债/权益比越低杠杆越低 | — | 0.09× |
8季度趋势，按日历期对齐
现金及短期投资BCPCRKLB
| Q4 25 | $74.6M | $1.0B | ||
| Q3 25 | $65.1M | $976.7M | ||
| Q2 25 | $65.4M | $688.1M | ||
| Q1 25 | $49.9M | $428.4M | ||
| Q4 24 | $49.5M | $419.0M | ||
| Q3 24 | $73.7M | $442.4M | ||
| Q2 24 | $63.7M | $496.8M | ||
| Q1 24 | $60.3M | $492.5M |
总债务BCPCRKLB
| Q4 25 | — | $152.4M | ||
| Q3 25 | — | $347.0M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $345.9M | ||
| Q4 24 | — | $345.4M | ||
| Q3 24 | — | $61.2M | ||
| Q2 24 | — | $64.2M | ||
| Q1 24 | — | $66.8M |
股东权益BCPCRKLB
| Q4 25 | $1.3B | $1.7B | ||
| Q3 25 | $1.3B | $1.3B | ||
| Q2 25 | $1.3B | $688.5M | ||
| Q1 25 | $1.2B | $431.3M | ||
| Q4 24 | $1.1B | $382.5M | ||
| Q3 24 | $1.2B | $419.8M | ||
| Q2 24 | $1.1B | $455.2M | ||
| Q1 24 | $1.1B | $478.9M |
总资产BCPCRKLB
| Q4 25 | $1.7B | $2.3B | ||
| Q3 25 | $1.7B | $2.2B | ||
| Q2 25 | $1.7B | $1.6B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.6B | $1.2B | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | $1.6B | $1.2B | ||
| Q1 24 | $1.6B | $1.2B |
负债/权益比BCPCRKLB
| Q4 25 | — | 0.09× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.80× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | $-64.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-114.2M |
| 自由现金流率自由现金流/营收 | — | -63.6% |
| 资本支出强度资本支出/营收 | — | 27.6% |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | — | $-321.8M |
8季度趋势，按日历期对齐
经营现金流BCPCRKLB
| Q4 25 | $67.3M | $-64.5M | ||
| Q3 25 | $65.6M | $-23.5M | ||
| Q2 25 | $47.3M | $-23.2M | ||
| Q1 25 | $36.5M | $-54.2M | ||
| Q4 24 | $52.3M | $-2.4M | ||
| Q3 24 | $51.3M | $-30.9M | ||
| Q2 24 | $45.0M | $-13.0M | ||
| Q1 24 | $33.4M | $-2.6M |
自由现金流BCPCRKLB
| Q4 25 | — | $-114.2M | ||
| Q3 25 | — | $-69.4M | ||
| Q2 25 | — | $-55.3M | ||
| Q1 25 | — | $-82.9M | ||
| Q4 24 | — | $-23.9M | ||
| Q3 24 | — | $-41.9M | ||
| Q2 24 | — | $-28.3M | ||
| Q1 24 | — | $-21.8M |
自由现金流率BCPCRKLB
| Q4 25 | — | -63.6% | ||
| Q3 25 | — | -44.8% | ||
| Q2 25 | — | -38.3% | ||
| Q1 25 | — | -67.6% | ||
| Q4 24 | — | -18.1% | ||
| Q3 24 | — | -40.0% | ||
| Q2 24 | — | -26.7% | ||
| Q1 24 | — | -23.5% |
资本支出强度BCPCRKLB
| Q4 25 | — | 27.6% | ||
| Q3 25 | — | 29.6% | ||
| Q2 25 | — | 22.2% | ||
| Q1 25 | — | 23.4% | ||
| Q4 24 | — | 16.3% | ||
| Q3 24 | — | 10.5% | ||
| Q2 24 | — | 14.4% | ||
| Q1 24 | — | 20.7% |
现金转化率BCPCRKLB
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | 1.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
RKLB
| Products | $94.0M | 52% |
| Transferred Over Time | $87.3M | 49% |
